Jefferies upgraded Jazz Pharmaceuticals (NASDAQ: JAZZ) from Hold to Buy with a price target of $52.00 (up from $29).

This article: 124 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE